NCT01589666View on ClinicalTrials.gov

Safety Study of Spray-Dried Solvent/Detergent-Treated Plasma for Infusion in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

September 9, 2016

Study Completion Date

September 9, 2016

Conditions
Coagulation Defects
Interventions
BIOLOGICAL

Spray-dried S/D-treated Plasma

Infusion of 100 mL Spray-dried S/D-treated Plasma

DRUG

Spray-dried S/D-treated plasma

Infusion of 200mL Spray-dried S/D-treated plasma

BIOLOGICAL

Spray-dried S/D-treated Plasma

Infusion of 500 mL Spray-dried S/D-treated plasma

BIOLOGICAL

Spray-dried S/D-treated Plasma

Infusion of 750 mL Spray-dried S/D-treated Plasma

BIOLOGICAL

Spray-dried S/D-treated Plasma

Infusion of 800 mL Spray-dried S/D-treated Plasma

Trial Locations (1)

66212

Vince & Associates Clinical Research, Overland Park

Sponsors

Lead Sponsor

Entegrion, Inc.
All Listed Sponsors
lead

Entegrion, Inc.

INDUSTRY